EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

RAD18 ‐ and BRCA1 ‐dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir

Tasnim Ahmad, Ryotaro Kawasumi, Kouji Hirota iD

Genes to Cells · 2024

DOI: 10.1111/gtc.13155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Tasnim Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Hachioji-shi, Tokyo, Japan. Hauptthemen laut MEDLINE: BRCA1 Protein, Ganciclovir, DNA Breaks, Double-Stranded, DNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tokyo Metropolitan Government, Japan Society for the Promotion of Science, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganciclovir (GCV) is a clinically important drug as it is used to treat viral infections. GCV is incorporated into the DNA during replication, where it interferes with subsequent replication on GCV‐incorporated templates. However, the effects of GCV on the host genome and the mechanisms underlying cellular tolerance to GCV remain unclear. In this study, we explored these mechanisms using a collection of mutant DT40 cells. We identified RAD17 /− , BRCA1 −/− , and RAD18 −/− cells as highly GCV‐sensitive. RAD17, a component of the alternative checkpoint‐clamp loader RAD17‐RFC, was required for the activation of the intra‐S checkpoint following GCV treatment. BRCA1, a critical factor for promoting homologous recombination (HR), was required for suppressing DNA double‐strand breaks (DSBs). Moreover, RAD18, an E3‐ligase involved in DNA repair, was critical in suppressing the aberrant ligation of broken chromosomes caused by GCV. We found that BRCA1 suppresses DSBs through HR‐mediated repair and template switching (TS)‐mediated damage bypass. Moreover, the strong GCV sensitivity of BRCA1 −/− cells was rescued by the loss of 53BP1, despite the only partial restoration in the sister chromatid exchange events which are hallmarks of HR. These results indicate that BRCA1 promotes cellular tolerance to GCV through two mechanisms, TS and HR‐mediated repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinGanciclovirDNA Breaks, Double-StrandedDNA-Binding ProteinsAnimalsHumansDNA RepairHomologous RecombinationCell LineAntiviral AgentsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

BRCA1homologous recombination (HR)nucleoside analogreplicationtemplate switch (TS)

Substanzen

BRCA1 ProteinGanciclovirDNA-Binding ProteinsBRCA1 protein, humanRAD18 protein, humanAntiviral AgentsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Hachioji-shi, Tokyo, Japan.

ORCID-Profile: Kouji Hirota

Förderung

  • Tokyo Metropolitan Government
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Yamada Science Foundation

Zitieren

APA

Ahmad, T., Kawasumi, R., & Hirota, K. (2024). RAD18 ‐ and BRCA1 ‐dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir. Genes to Cells. https://doi.org/10.1111/gtc.13155

Vancouver

Ahmad T, Kawasumi R, Hirota K. RAD18 ‐ and BRCA1 ‐dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir. Genes to Cells. 2024. doi:10.1111/gtc.13155

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Tasnim and Kawasumi, Ryotaro and Hirota, Kouji},
  title = {RAD18 ‐ and BRCA1 ‐dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir},
  journal = {Genes to Cells},
  year = {2024},
  doi = {10.1111/gtc.13155}
}
Kostenlos starten →